Medtronic plc
MDT · NYSE
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $4,691,000 | $3,676,000 | $3,784,000 | $5,062,000 |
| Dep. & Amort. | $2,861,000 | $2,647,000 | $2,697,000 | $2,707,000 |
| Deferred Tax | -$316,000 | -$508,000 | -$226,000 | -$604,000 |
| Stock-Based Comp. | $429,000 | $393,000 | $355,000 | $359,000 |
| Change in WC | -$1,054,000 | -$484,000 | -$967,000 | -$889,000 |
| Other Non-Cash | $433,000 | $1,063,000 | $396,000 | $711,000 |
| Operating Cash Flow | $7,044,000 | $6,787,000 | $6,039,000 | $7,346,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,859,000 | -$1,587,000 | -$1,459,000 | -$1,368,000 |
| Net Acquisitions | -$98,000 | -$211,000 | -$1,867,000 | -$91,000 |
| Inv. Purchases | -$8,226,000 | -$7,748,000 | -$7,514,000 | -$9,882,000 |
| Inv. Sales/Matur. | $8,495,000 | $7,441,000 | $7,343,000 | $9,692,000 |
| Other Inv. Act. | -$249,000 | -$261,000 | $4,000 | -$10,000 |
| Investing Cash Flow | -$1,937,000 | -$2,366,000 | -$3,493,000 | -$1,659,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2,139,000 | $1,073,000 | -$598,000 | -$1,000 |
| Stock Issued | $508,000 | $284,000 | $308,000 | $429,000 |
| Stock Repurch. | -$3,235,000 | -$2,138,000 | -$645,000 | -$2,544,000 |
| Dividends Paid | -$3,589,000 | -$3,666,000 | -$3,616,000 | -$3,383,000 |
| Other Fin. Act. | -$184,000 | -$3,000 | -$409,000 | $163,000 |
| Financing Cash Flow | -$4,361,000 | -$4,450,000 | -$4,960,000 | -$5,336,000 |
| Forex Effect | $188,000 | -$230,000 | $243,000 | -$230,000 |
| Net Chg. in Cash | $934,000 | -$259,000 | -$2,171,000 | $121,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,284,000 | $1,543,000 | $3,714,000 | $3,593,000 |
| End Cash | $2,218,000 | $1,284,000 | $1,543,000 | $3,714,000 |
| Free Cash Flow | $5,185,000 | $5,200,000 | $4,580,000 | $5,978,000 |